Mutual Funds Blogs Videos

No results found

did not match any result. Please try again.

Clear Search BackGround
Need Help?
0

Nippon India Pharma Fund vs Mirae Asset Healthcare Fund compare

Link copied to clipboard!

tortoise-icon Nippon India Pharma Fund-Growth Plan-Growth Option

Invest Now

tortoise-icon Mirae Asset Healthcare Fund -Regular Growth

Invest Now

Chart Comparison

Overview Trailing Returns SIP Returns Rolling Returns Risk Managers Market Cap Sectors

Overview

Scheme Name Nippon India Pharma Fund-Growth Plan-Growth Option Mirae Asset Healthcare Fund -Regular Growth
Fund Nippon India Pharma Fund-Growth Plan-Growth Option Mirae Asset Healthcare Fund -Regular Growth
Investment Plan Growth Growth
Level of Risk Very High Very High
Asset Size (Cr) ₹8265 Cr ₹2771 Cr
Min Investment ₹5000 ₹5000
Min SIP Invesment ₹500 ₹99
Min Addl Investment ₹1000 ₹1000
Launch Date 05 Jun 2004 02 Jul 2018
Category Pharma & Healthcare Pharma & Healthcare
Fund Type Open Ended Open Ended
Benchmark BSE Healthcare BSE Healthcare
Turn Over 21% 15%
Expense Ratio 1.82 1.92
Manager Sailesh Raj Bhan Vrijesh Kasera
ISIN Code INF204K01968 INF769K01EA2
Exits Load Nippon India Pharma Fund - Growth charges 1.0% of sell value; if fund sold before 30 days. There are no other charges./365 Mirae Asset Healthcare Fund - Growth charges 1.0% of sell value; if fund sold before 365 days. There are no other charges./365

Trailing Lumpsum Returns

Scheme Name Nippon India Pharma Fund-Growth Plan-Growth Option Mirae Asset Healthcare Fund -Regular Growth
1 Month -3.48% -3.94%
6 Month -9.21% -9.19%
1 Year 1.71% 0.37%
3 Year 20.8% 20.23%
5 Year 14.86% 15.2%

SIP Return Analysis

Scheme Name Nippon India Pharma Fund-Growth Plan-Growth Option Mirae Asset Healthcare Fund -Regular Growth
6 Month -0.33% -0.75%
1 Year 3.37% 4.1%
3 Year 13.78% 14.75%
5 Year 15.1% 15.02%

Rolling Lumpsum Returns

Scheme Name Nippon India Pharma Fund-Growth Plan-Growth Option Mirae Asset Healthcare Fund -Regular Growth
1 Year 16.54% 18.85%
3 Year 21% 20.62%
5 Year 20.33% 22.96%

Risk Management

Scheme Name Nippon India Pharma Fund-Growth Plan-Growth Option Mirae Asset Healthcare Fund -Regular Growth
Standard Deviation 15.10% 16.17%
Sharp 0.96% 0.90%
Beta 0.91% 0.99%
Alpha -0.54% -1.63%

Fund Managers

Scheme Name Nippon India Pharma Fund-Growth Plan-Growth Option Mirae Asset Healthcare Fund -Regular Growth
Name Sailesh Raj Bhan Vrijesh Kasera
Total AUM ₹96086 Cr ₹12061 Cr
Funds Managed 5 4
Nippon India Pharma Fund-Growth Plan-Growth Option Mirae Asset Healthcare Fund -Regular Growth

Market Cap

Scheme Name

Nippon India Pharma Fund-Growth Plan-Growth Option

Mirae Asset Healthcare Fund -Regular Growth

Others 3.47 6.66
Mid Cap 34.55 36.33
Small Cap 29.97 23.1
Large Cap 32.01 33.91

Sector Allocation

Scheme Name

Nippon India Pharma Fund-Growth Plan-Growth Option

Mirae Asset Healthcare Fund -Regular Growth

Others 2.63 0.54
Healthcare 97.37 98.24
Basic Materials - 1.22

Top Comparisons

ICICI Prudential Value Fund - Growth ICICI Prudential Value Fund - Growth

3Y Returns20.59%

VS

Canara Robeco Value Fund - Regular Plan - Growth Option Canara Robeco Value Fund - Regular Plan - Growth Option

3Y Returns17.35%

Compare Now

SBI Equity Savings Fund - Regular Plan - Growth SBI Equity Savings Fund - Regular Plan - Growth

3Y Returns11.6%

VS

Baroda BNP Paribas Equity Savings Fund - Regular Plan - Growth Baroda BNP Paribas Equity Savings Fund - Regular Plan - Growth

3Y Returns10.32%

Compare Now

ICICI Prudential Liquid Fund - Growth ICICI Prudential Liquid Fund - Growth

3Y Returns6.91%

VS

Sundaram Liquid Fund (G) Sundaram Liquid Fund (G)

3Y Returns6.86%

Compare Now

Invesco India - Invesco Pan European Equity Fund of Fund - Regular Plan - Growth Option Invesco India - Invesco Pan European Equity Fund of Fund - Regular Plan - Growth Option

3Y Returns18.26%

VS

ADITYA BIRLA SUN LIFE US TREASURY 3-10 YEAR BOND ETFS PASSIVE FOF - REGULAR PLAN - GROWTH ADITYA BIRLA SUN LIFE US TREASURY 3-10 YEAR BOND ETFS PASSIVE FOF - REGULAR PLAN - GROWTH

3Y Returns0%

Compare Now
Add to Cart Successfully